Dissemination and evaluation of the 3E initiative recommendations for use of methotrexate in rheumatic disorders: Results of a study among 2233 rheumatologists

Annals of the Rheumatic Diseases

Volumn 70, Issue 2, 2011, Pages 388-389

  Gossec, L ^a   Bijlsma, J W J ^b   Bombardier, C ^c   Canhao H ^d,e   Devlin, J ^f   Edwards, C J ^g   Hamuryudan, V ^h   Kvien, T K ⁱ   Leeb, B F ^j   Martin Mola E M ^k   Mielants, H ^l   Muller Ladner U ^m   Ostergaard M ⁿ   Pereira, I A ^o   Ramos Remus, C ^p   Zochling, J ^q   Dougados, Maxime ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF LISBON   (Portugal)

^e HOSPITAL DE SANTA MARIA   (Portugal)

^f WATERFORD REGIONAL HOSPITAL   (Ireland)

^g UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^h ISTANBUL UNIVERSITY   (Turkey)

ⁱ DIAKONHJEMMET HOSPITAL   (Norway)

^j State Hospital Stockerau   (Austria)

^k HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^l GHENT UNIVERSITY   (Belgium)

^m JUSTUS LIEBIG UNIVERSITY   (Germany)

ⁿ UNIVERSITY OF COPENHAGEN   (Denmark)

^o FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^p Unidad de Investigacion en Enfermedades Cronico Degenerativas   (Mexico)

^q UNIVERSITY OF TASMANIA   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; FOLIC ACID; METHOTREXATE;

CLINICAL PRACTICE; DEMOGRAPHY; DERMATOMYOSITIS; EVALUATION; GIANT CELL ARTHRITIS; HUMAN; LETTER; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; SELF REPORT; STATISTICAL ANALYSIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIRHEUMATIC AGENTS; HUMANS; INFORMATION DISSEMINATION; METHOTREXATE; PRACTICE GUIDELINES AS TOPIC; RHEUMATIC DISEASES;

EID: 78751700659     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2010.128652     Document Type: Letter

References (4)

1. Visser K, Katchamart W, Loza E, et al. Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E initiative. Ann Rheum Dis 2009;68:1086-93.
2. Grimshaw J, McAuley LM, Bero LA, et al. Systematic reviews of the effectiveness of quality improvement strategies and programmes. Qual Saf Health Care 2003;12:298-303. (Pubitemid 36981329)
3. Dougados M, Betteridge N, Burmester GR, et al.; EULAR. EULAR standardised operating procedures for the elaboration, evaluation, dissemination, and implementation of recommendations endorsed by the EULAR standing committees. Ann Rheum Dis 2004;63:1172-6.
4. Gossec L, Dougados M, Phillips C, et al.; ASAS (ASsessment in AS international working group). Dissemination and evaluation of the ASAS/EULAR recommendations for the management of ankylosing spondylitis: results of a study among 1507 rheumatologists. Ann Rheum Dis 2008;67:782-8.